ForeverLabs

Regenerative Medicine Insights

Clinical trials, aesthetic applications, regulatory updates, research studies, and industry insights from the world of regenerative medicine

Latest Articles

DTd6cp_Jrzew1kBqwMTSn.jpg
Clinical
1 min read
Web
Stem Cells in Clinical Trials for Pelvic Floor Disorders: a Systematic Literature Review
Authors: Stefano Manodoro, Matteo Frigerio, Marta Barba, Sara Bosio, Luigi Antonio de Vitis, Anna Maria Marconi
Pelvic FloorClinical TrialsStress urinary incontinenceAnal IncontinenceWomen's Health
AI generated image for: Autologous hematopoietic stem cell transplantation in multiple sclerosis: a phase II trial
Clinical
1 min read
Neurology
Autologous hematopoietic stem cell transplantation in multiple sclerosis: a phase II trial
This phase II randomized trial demonstrates that autologous hematopoietic stem cell transplantation (AHSCT) is significantly more effective than mitoxantrone at reducing MRI-detected disease activity in patients with aggressive multiple sclerosis. Results showed a 79% reduction in new T2 lesions and a significant decrease in relapse rates, supporting the need for larger phase III clinical trials.
Autologous Hematopoietic Cell TransplantationImmunosuppressionClinical TrialsMultiple Sclerosis